{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Seymour",
      "state": "IN",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91142",
      "recalling_firm": "Lannett Company Inc.",
      "address_1": "1101 C Ave W",
      "address_2": "N/A",
      "postal_code": "47274-3342",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide USA",
      "recall_number": "D-0160-2023",
      "product_description": "Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136.   NDC: 0527-1632-10",
      "product_quantity": "5,640 bottles",
      "reason_for_recall": "Failed Impurity/Degradation Specifications",
      "recall_initiation_date": "20221109",
      "center_classification_date": "20230116",
      "termination_date": "20230608",
      "report_date": "20230125",
      "code_info": "Lots: 20256318A (12/2022), 20256321A (12/2022), 21000238A (01/2023)"
    }
  ]
}